Literature DB >> 34826549

Jujuboside A ameliorates high fat diet and streptozotocin induced diabetic nephropathy via suppressing oxidative stress, apoptosis, and enhancing autophagy.

Yujie Zhong1, Ruilin Luo1, Qi Liu1, Jiachang Zhu1, Min Lei1, Xiaofei Liang1, Xin Wang1, Xiaoli Peng2.   

Abstract

Jujuboside A (JuA) is a triterpenoid saponins isolated from the seed of jujube (semen Ziziphi spinosae) with anti-oxidant, anti-inflammation and anti-apoptosis properties. The present study aimed to investigate the reno-protective effects of JuA on type II diabetes. JuA (20 mg/kg) and Metformin (Met, 300 mg/kg) were administrated to diabetic Sprague Dawley rat for 8 weeks daily. Our results showed that JuA reduced blood glucose and kidney function markers including 24 h urinary protein, urinary β-NAG/urinary creatinine, serum urea nitrogen, serum uric acid and serum creatinine, and relieved renal pathological changes. In addition, JuA decreased O2- and H2O2 level, enhanced SOD, CAT and GPx activities, decreased NOX4 expression and improved mitochondrial respiratory chain function through regulating respiratory chain complex expression. Moreover, JuA downregulated the expressions of mitochondrial apoptosis proteins: Bax, CytC, Apaf-1 and caspase 9. Apoptosis mediated by ER stress also been inhibited by JuA via downregulating p-PERK, p-IRE1, XBP1s, ATF4, p-CHOP and caspase 12 expressions. JuA also enhanced autophagy and mitophagy via regulating CaMKK2-AMPK-p-mTOR and PINK1/Parkin pathways. Collectively, these results indicated that JuA protected against type II diabetic nephropathy through inhibiting oxidative stress and apoptosis mediated by mitochondria and ER stress. In addition, autophagy and mitophagy was enhanced by JuA.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Autophagy; Diabetic nephropathy; Jujuboside A; Oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 34826549     DOI: 10.1016/j.fct.2021.112697

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  4 in total

1.  Effects of Qidantang Granule on early stage of diabetic kidney disease in rats.

Authors:  Tengfei Wu; Xinyu Yang; Yilei Cong; Shisi Xia; Bowen Liu; Ran Zou; Juanhua Zeng; Hua Yang
Journal:  Aging (Albany NY)       Date:  2022-06-13       Impact factor: 5.955

2.  Empagliflozin-Enhanced Antioxidant Defense Attenuates Lipotoxicity and Protects Hepatocytes by Promoting FoxO3a- and Nrf2-Mediated Nuclear Translocation via the CAMKK2/AMPK Pathway.

Authors:  Yangyang Wang; Yipei Ding; Pengbo Sun; Wanqiu Zhang; Qilei Xin; Ningchao Wang; Yaoyun Niu; Yang Chen; Jingyi Luo; Jinghua Lu; Jin Zhou; Naihan Xu; Yaou Zhang; Weidong Xie
Journal:  Antioxidants (Basel)       Date:  2022-04-19

3.  Protective Effects of Jujubosides on 6-OHDA-Induced Neurotoxicity in SH-SY5Y and SK-N-SH Cells.

Authors:  Chao-Hsuan Chen; Pei-Chen Hsu; Shih-Wei Hsu; Kun-Ting Hong; Kai-Yuan Chen; Jie-Long He; Der-Yang Cho; Yun-Chi Wang; Wen-Shin Chang; Da-Tian Bau; Chia-Wen Tsai
Journal:  Molecules       Date:  2022-06-26       Impact factor: 4.927

Review 4.  The critical role of dysregulated autophagy in the progression of diabetic kidney disease.

Authors:  Ziwei Zhang; Yuting Sun; Jiaojiao Xue; Xiangyan Li; Daqing Zhao; Fengmei Lian; Wenxiu Qi; Xiaolin Tong
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.